Because we had found a strong increase in bulk and tumor-specific CD8+ TILs upon hRT/lena dual treatment compared with all other treatment groups (Figure 2F and Figure S2A), we wanted to determine whether the addition of lena to hRT affects effector functions and exhaustion state of the tumor-specific TILs. Here, CD8A is linked to neoplasm.